These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2074518)

  • 1. Detection of exfoliated bladder cancer cells by monoclonal antibodies to tumor-associated cell surface antigens.
    Lin CW; Kirley SD; Khaw AH; Zhang DS; Prout GR
    J Occup Med; 1990 Sep; 32(9):910-6. PubMed ID: 2074518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of tumor cells in bladder washings by a monoclonal antibody to human bladder tumor-associated antigen.
    Lin CW; Young DA; Kirley SD; Khaw AH; Prout GR
    J Urol; 1988 Sep; 140(3):672-7. PubMed ID: 3045345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemical and biochemical characterizations of two monoclonal antibody-reacting antigens associated with human bladder carcinoma.
    Zhang DS; Lin CW
    Cancer Res; 1989 Dec; 49(23):6621-8. PubMed ID: 2819713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.
    Gilbert SM; Veltri RW; Sawczuk A; Shabsigh A; Knowles DR; Bright S; O'Dowd GJ; Olsson CA; Benson MC; Sawczuk IS
    Urology; 2003 Mar; 61(3):539-43. PubMed ID: 12639642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
    Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
    Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens.
    Young DA; Prout GR; Lin CW
    Cancer Res; 1985 Sep; 45(9):4439-46. PubMed ID: 3896480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in murine monoclonal-antibody-defined urinary antigens in patients with bladder cancer and benign urogenital disease.
    Masuko T; Sugahara K; Kamiya T; Hashimoto Y
    Int J Cancer; 1989 Oct; 44(4):582-8. PubMed ID: 2676868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder.
    Huland E; Huland H; Meier T; Baricordi O; Fradet Y; Grossman HB; Hodges GM; Messing EM; Schmitz-Draeger BJ
    J Urol; 1991 Dec; 146(6):1631-6. PubMed ID: 1719252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells.
    Bonner RB; Hemstreet GP; Fradet Y; Rao JY; Min KW; Hurst RE
    Cancer; 1993 Oct; 72(8):2461-9. PubMed ID: 8402463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced detection of bladder cancer using the epithelial surface marker epithelial membrane antigen: a preliminary report.
    Ring KS; Karp F; Benson MC
    J Occup Med; 1990 Sep; 32(9):904-9. PubMed ID: 2074517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of malignant cells in voided urine from patients with bladder cancer, a novel monoclonal assay.
    Walker KZ; Russell PJ; Kingsley EA; Philips J; Raghavan D
    J Urol; 1989 Dec; 142(6):1578-83. PubMed ID: 2685375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced detection of bladder cancer in urine cytology with Lewis X, M344 and 19A211 antigens.
    Sagerman PM; Saigo PE; Sheinfeld J; Charitonowics E; Cordon-Cardo C
    Acta Cytol; 1994; 38(4):517-23. PubMed ID: 7913791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bladder tumor antigen (BTA) test compared to voided urine cytology in the detection of bladder neoplasms.
    Murphy WM; Rivera-Ramirez I; Medina CA; Wright NJ; Wajsman Z
    J Urol; 1997 Dec; 158(6):2102-6. PubMed ID: 9366322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Field molecular epidemiology. Feasibility of monitoring for the malignant bladder cell phenotype in a benzidine-exposed occupational cohort.
    Bi W; Rao JY; Hemstreet GP; Fang P; Asal NR; Zang M; Min KW; Ma Z; Lee E; Li G
    J Occup Med; 1993 Jan; 35(1):20-7. PubMed ID: 7678643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine cytology: early diagnosis of induced carcinoma of the rat urinary bladder.
    Reznik G; Brennan LM; Creasia DA
    Anticancer Res; 1981; 1(6):389-92. PubMed ID: 7344612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative fluorescence image analysis in bladder cancer screening.
    Hemstreet GP; Hurst RE; Bass RA; Rao JY
    J Occup Med; 1990 Sep; 32(9):822-8. PubMed ID: 2074505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer.
    Kinoshita H; Ogawa O; Kakehi Y; Mishina M; Mitsumori K; Itoh N; Yamada H; Terachi T; Yoshida O
    J Natl Cancer Inst; 1997 May; 89(10):724-30. PubMed ID: 9168188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the DD23 tumor-associated antigen for bladder cancer detection and recurrence monitoring. Marker Network for Bladder Cancer.
    Bonner RB; Liebert M; Hurst RE; Grossman HB; Bane BL; Hemstreet GP
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):971-8. PubMed ID: 8959319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.